Cancer Research UK logo.
SearchDonate
  • Search

A trial of pembrolizumab and a new drug called guadecitabine for people with solid tumours (HyPeR)

Overview

Cancer types:

All cancer types, Secondary cancers

Status:

Closed

Phase:

Phase 1

Details

This trial is for people with a solid tumour that has spread or continued to grow despite treatment (refractory). A solid tumour is any type of cancer apart from those of the blood or lymphatic system such as:

  • leukaemia

  • lymphoma

  • myeloma

Recruitment start: 1 January 2017

Recruitment end: 31 December 2019

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Johann de Bono

Supported by

ASTEX Pharmaceuticals

Institute of Cancer Research (ICR)

MSD

The Royal Marsden NHS Foundation Trust

Last reviewed: 6 January 2020

CRUK internal database number: 15517

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.